A. Vipin Menon

A. Vipin Menon

Auto-generated profile, based on publicly available information

A. Vipin Menon

Department of Life Science, Hanyang University, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2016 in Nature Methods
Verified
Journal Article
Closed access
HKHui K Kim
Hui K Kim
MSMyungjae Song
Myungjae Song
Jinu LeeJinu Lee
Jinu Lee
AMA Vipin Menon
A Vipin Menon
SJSoobin Jung
Soobin Jung
HKHyongbum Kim
Hyongbum Kim

8 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
BCBumsik Cho
Bumsik Cho
SYSang-Ho Yoon
Sang-Ho Yoon
DLDaewon Lee
Daewon Lee
FKFerdinand Koranteng
Ferdinand Koranteng
STSudhir Gopal Tattikota
Sudhir Gopal Tattikota
JSJiwon Shim
Jiwon Shim
The Drosophila lymph gland, the larval hematopoietic organ comprised of prohemocytes and mature hemocytes, has been a valuable model for understanding mechanisms underlying hematopoiesis and immunity. Three types of mature hemocytes have been characterized in the lymph gland: plasmatocytes, lamellocytes, and crystal cells, which are analogous to vertebrate myeloid cells, yet molecular underpinnings of the lymph gland hemocytes have been less investigated. Here, we use single-cell RNA sequencing to comprehensively analyze heterogeneity of developing hemocytes in the lymph gland, and discover previously undescribed hemocyte types including adipohemocytes, stem-like prohemocytes, and intermediate prohemocytes. Additionally, we identify the developmental trajectory of hemocytes during normal development as well as the emergence of the lamellocyte lineage following active cellular immunity caused by wasp infestation. Finally, we establish similarities and differences between embryonically derived- and larval lymph gland hemocytes. Altogether, our study provides detailed insights into the hemocyte development and cellular immune responses at single-cell resolution.

15 September 2014 in Scientific Reports
Verified
Journal Article
Open access
ARAparna Rai
Aparna Rai
AMA. Vipin Menon
A. Vipin Menon
SJSarika Jalan
Sarika Jalan
Breast cancer has been reported to account for the maximum cases among all female cancers till date. In order to gain a deeper insight into the complexities of the disease, we analyze the breast cancer network and its normal counterpart at the proteomic level. While the short range correlations in the eigenvalues exhibiting universality provide an evidence towards the importance of random connections in the underlying networks, the long range correlations along with the localization properties reveal insightful structural patterns involving functionally important proteins. The analysis provides a benchmark for designing drugs which can target a subgraph instead of individual proteins.

1 January 2020 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
AMA Vipin Menon
A Vipin Menon
JSJang-Il Sohn
Jang-Il Sohn
Jin-Wu NamJin-Wu Nam
Jin-Wu Nam
The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas systems, including dead Cas9 (dCas9), Cas9, and Cas12a, have revolutionized genome engineering in mammalian somatic cells. Although computational tools that assess the target sites of CRISPR-Cas systems are inevitably important for designing efficient guide RNAs (gRNAs), they exhibit generalization issues in selecting features and do not provide optimal results in a comprehensive manner. Here, we introduce a Comprehensive Guide Designer (CGD) for four different CRISPR systems, which utilizes the machine learning algorithm, Elastic Net Logistic Regression (ENLOR), to autonomously generalize the models. CGD contains specific models trained with public datasets generated by CRISPRi, CRISPRa, CRISPR-Cas9, and CRISPR-Cas12a (designated as CGDi, CGDa, CGD9, and CGD12a, respectively) in an unbiased manner. The trained CGD models were benchmarked to other regression-based machine learning models, such as ElasticNet Linear Regression (ENLR), Random Forest and Boruta (RFB), and Extreme Gradient Boosting (Xgboost) with inbuilt feature selection. Evaluation with independent test datasets showed that CGD models outperformed the pre-existing methods in predicting the efficacy of gRNAs. All CGD source codes and datasets are available at GitHub (https://github.com/vipinmenon1989/CGD), and the CGD webserver can be accessed at http://big.hanyang.ac.kr:2195/CGD.

19 December 2022 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
JSJang-Il Sohn
Jang-Il Sohn
MCMin-Hak Choi
Min-Hak Choi
DYDohun Yi
Dohun Yi
VMVipin A. Menon
Vipin A. Menon
YKYeon Jeong Kim
Yeon Jeong Kim
Jin-Wu NamJin-Wu Nam
Jin-Wu Nam

26 October 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
MCMin-Hak Choi
Min-Hak Choi
JSJang-Il Sohn
Jang-Il Sohn
DYDohun Yi
Dohun Yi
AMA Vipin Menon
A Vipin Menon
YKYeon Jeong Kim
Yeon Jeong Kim
Jin-Wu NamJin-Wu Nam
Jin-Wu Nam
Genome rearrangements often result in copy number alterations of cancer-related genes and cause the formation of cancer-related fusion genes. Current structural variation (SV) callers, however, still produce massive numbers of false positives (FPs) and require high computational costs. Here, we introduce an ultra-fast and high-performing somatic SV detector, called ETCHING, that significantly reduces the mapping cost by filtering reads matched to pan-genome and normal k -mer sets. To reduce the number of FPs, ETCHING takes advantage of a Random Forest classifier that utilizes six breakend-related features. We systematically benchmarked ETCHING with other SV callers on reference SV materials, validated SV biomarkers, tumor and matched-normal whole genomes, and tumor-only targeted sequencing datasets. For all datasets, our SV caller was much faster (≥15X) than other tools without compromising performance or memory use. Our approach would provide not only the fastest method for largescale genome projects but also an accurate clinically practical means for real-time precision medicine.